INBX insider transaction filings
Inhibrx Biosciences, Inc. — 13 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-06-04. Screen INBX transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-04 | 4 | Vuori Kristiina MD — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2026-06-04 | 4 | Kayyem Jon Faiz — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2026-06-04 | 4 | FORSYTH DOUGLAS — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2026-06-04 | 4 | MANHARD KIMBERLY — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2026-04-27 | 4 | Matly David — President | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-10-09 | 4 | VIKING GLOBAL INVESTORS LP — 10% owner Viking Global Opportunities Parent GP LLC — 10% owner Viking Global Opportunities GP LLC — 10% owner Viking Global Opportunities Portfolio GP LLC — 10% owner Viking Global Opportunities Illiquid Investments Sub-Master LP — 10% owner HALVORSEN OLE ANDREAS — 10% owner Ott David C. — 10% owner Shabet Rose Sharon — 10% owner | Sale (S): 308,643 @ $32.25 · Sale (S): 16,315 @ $32.25 · Sale (S): 25,042 @ $32.25 | EDGAR |
| 2025-05-29 | 4 | Vuori Kristiina MD — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2025-05-29 | 4 | Kayyem Jon Faiz — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2025-05-29 | 4 | FORSYTH DOUGLAS — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2025-05-29 | 4 | MANHARD KIMBERLY — Director | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | Matly David — President | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | Deck Kelly — Chief Financial Officer | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2025-03-28 | 4 | Kayyem Jon Faiz — Director | Gift (G): 90,000 @ $0 | EDGAR |
Recent 8-K events — Inhibrx Biosciences, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-16 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-15 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-03 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-11 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-21 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-19 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-23 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-16 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=INBX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →